<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00761085</url>
  </required_header>
  <id_info>
    <org_study_id>201107091</org_study_id>
    <nct_id>NCT00761085</nct_id>
  </id_info>
  <brief_title>Methadone in Pediatric and Adult Sickle Cell Patients</brief_title>
  <acronym>MSCD</acronym>
  <official_title>Methadone in Pediatric and Adult Sickle Cell Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the pharmacokinetics of methadone in children and adults with SCD who are
      experiencing a painful episode.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2008</start_date>
  <completion_date type="Actual">November 7, 2010</completion_date>
  <primary_completion_date type="Actual">November 7, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To Determine the Pharmacokinetics of Methadone in Children and Adults With Sickle Cell Disease Experiencing a VOE.</measure>
    <time_frame>96 hr</time_frame>
    <description>R-Methadone AUC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Relief</measure>
    <time_frame>72 hr</time_frame>
    <description>Pain relief score using the 10CM VAS, which has a pain scale of 0-10, with 0=no pain and 10=worst pain experienced</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Sickle Cell Disease</condition>
  <arm_group>
    <arm_group_label>Methadone-Children</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methadone comparison to standard of care for pain management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine-Children</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Morphine standard of Care pain management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methadone-Adults</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methadone comparison to standard of care for pain management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine-Adults</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Morphine standard of Care pain management</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Standard of care for pain management of acute episode of pain</description>
    <arm_group_label>Morphine-Adults</arm_group_label>
    <arm_group_label>Morphine-Children</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
    <description>Compare to standard of care for pain management of acute episode of pain</description>
    <arm_group_label>Methadone-Adults</arm_group_label>
    <arm_group_label>Methadone-Children</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Greater than or equal to 7 years and less than or equal to 40 years

          -  Confirmed diagnosis of any form of sickle cell disease, including sickle cell anemia,
             sickle-hemoglobin C disease, and sickle-B thalassemia

          -  Currently experiencing a vaso-occlusive episode (VOE), defined as acute pain in the
             extremities

          -  Admitted to the inpatient unit for further treatment

          -  Started on morphine patient controlled analgesia and infusion for pain management

        Exclusion Criteria:

          -  Diagnosis of acute chest syndrome

          -  New focal neurologic findings or clinical concern of stroke

          -  Aplastic crisis with hemoglobin 2 g/dl below steady-state value

          -  Allergy to morphine or methadone

          -  Any other medical condition that the attending physician deems to be a
             contraindication to therapy

          -  Liver or renal insufficiency or failure, and congestive heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evan D Kharasch, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barnes Jewish Hospital/St. Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 24, 2008</study_first_submitted>
  <study_first_submitted_qc>September 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2008</study_first_posted>
  <results_first_submitted>June 18, 2018</results_first_submitted>
  <results_first_submitted_qc>January 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 22, 2020</results_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Methadone-Children</title>
          <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="P2">
          <title>Morphine-Children</title>
          <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="P3">
          <title>Methadone-Adults</title>
          <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="P4">
          <title>Morphine-Adults</title>
          <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Methadone-Children</title>
          <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="B2">
          <title>Morphine-Children</title>
          <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="B3">
          <title>Methadone-Adults</title>
          <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="B4">
          <title>Morphine-Adults</title>
          <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="11"/>
            <count group_id="B4" value="12"/>
            <count group_id="B5" value="47"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="11"/>
                    <count group_id="B4" value="12"/>
                    <count group_id="B5" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15" spread="2"/>
                    <measurement group_id="B2" value="14" spread="3"/>
                    <measurement group_id="B3" value="25" spread="6"/>
                    <measurement group_id="B4" value="25" spread="7"/>
                    <measurement group_id="B5" value="22" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="11"/>
                    <count group_id="B4" value="12"/>
                    <count group_id="B5" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="11"/>
                    <count group_id="B4" value="12"/>
                    <count group_id="B5" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>To Determine the Pharmacokinetics of Methadone in Children and Adults With Sickle Cell Disease Experiencing a VOE.</title>
        <description>R-Methadone AUC</description>
        <time_frame>96 hr</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone-Children</title>
            <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
          </group>
          <group group_id="O2">
            <title>Morphine-Children</title>
            <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
          </group>
          <group group_id="O3">
            <title>Methadone-Adults</title>
            <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
          </group>
          <group group_id="O4">
            <title>Morphine-Adults</title>
            <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
          </group>
        </group_list>
        <measure>
          <title>To Determine the Pharmacokinetics of Methadone in Children and Adults With Sickle Cell Disease Experiencing a VOE.</title>
          <description>R-Methadone AUC</description>
          <units>(hr*ng/ml)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="523" spread="248"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="637" spread="324"/>
                    <measurement group_id="O4" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>No statistical comparisons of methadone concentration in patients receiving methadone vs not receiving methadone (children or adults).
No statistical comparisons of methadone concentration in children vs adults</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>No statistical comparisons</non_inferiority_desc>
            <other_analysis_desc>No statistical comparisons</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief</title>
        <description>Pain relief score using the 10CM VAS, which has a pain scale of 0-10, with 0=no pain and 10=worst pain experienced</description>
        <time_frame>72 hr</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone-Children</title>
            <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
          </group>
          <group group_id="O2">
            <title>Morphine-Children</title>
            <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
          </group>
          <group group_id="O3">
            <title>Methadone-Adults</title>
            <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
          </group>
          <group group_id="O4">
            <title>Morphine-Adults</title>
            <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief</title>
          <description>Pain relief score using the 10CM VAS, which has a pain scale of 0-10, with 0=no pain and 10=worst pain experienced</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" spread="2"/>
                    <measurement group_id="O2" value="4" spread="3"/>
                    <measurement group_id="O3" value="5" spread="3"/>
                    <measurement group_id="O4" value="5" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Methadone-Children</title>
          <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="E2">
          <title>Morphine-Children</title>
          <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="E3">
          <title>Methadone-Adults</title>
          <description>Methadone comparison to standard of care for pain management
Methadone: Compare to standard of care for pain management of acute episode of pain</description>
        </group>
        <group group_id="E4">
          <title>Morphine-Adults</title>
          <description>Morphine standard of Care pain management
Morphine: Standard of care for pain management of acute episode of pain</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Evan Kharasch MD PhD</name_or_title>
      <organization>Washington University</organization>
      <phone>3143628796</phone>
      <email>kharasch@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

